Recursion Pharmaceuticals Inc (NASDAQ:RXRX) price on Wednesday, May 09, fall -2.28% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $8.59.
A look at the stock’s price movement, the close in the last trading session was $8.79. Turning to its 52-week performance, $16.75 and $4.92 were the 52-week high and 52-week low respectively. Overall, RXRX moved -5.50% over the past month.
Recursion Pharmaceuticals Inc’s market cap currently stands at around $2.04 billion.
Analysts have a consensus estimate of 12.65M for the company’s revenue for the quarter, with a low and high estimate of 10M and 20.8M respectively. The average forecast suggests up to a 4.30% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 56.16M, representing a 26.00% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RXRX is a 50% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
RXRX’s current price about 5.78% and -11.81% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.78, while 7-day volatility ratio is 5.59% and 5.88% in the 30-day chart. Further, Recursion Pharmaceuticals Inc (RXRX) has a beta value of 0.87, and an average true range (ATR) of 0.55.
If we refocus on Recursion Pharmaceuticals Inc (NASDAQ:RXRX), historical trading data shows that trading volumes averaged 6.43 million over the past 3 months. The company’s latest data on shares outstanding shows there are 226.26 million shares.
The 31.78% of Recursion Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 72.05% of the company’s shares. Current price change has pushed the stock -12.88% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RXRX stock continues to rise going into the next quarter.
